CVE-2025-8517 is a remotely exploitable session fixation vulnerability affecting givanz Vvveb version 1.0.6.1. The available information states that an unspecified function is impacted and that attacker-controlled manipulation can result in session fixation. In this condition, an attacker can cause a victim to use a session identifier chosen or known by the attacker, enabling the attacker to reuse that session after the victim authenticates or otherwise binds privileges to it. Public exploit information is reported to be available. The issue is addressed in Vvveb 1.0.7, with patch identifier d4b1e030066417b77d15b4ac505eed5ae7bf2c5e.
Mallory correlates every CVE against your assets, your vendors, and active adversary campaigns. Know which vulnerabilities matter for you, not just which ones are loud.
What it means. What to do now. Patch path, mitigations, and the assume-compromise checklist.
What an attacker gets, and what they’ve been doing with it.
If you can’t patch tonight, do this now.
Patch, then assume compromise.
No valid public exploits. Mallory filtered out 1 candidate as fakes, detection scripts, or README-only repos.
All candidate exploits were filtered out by Mallory's validation.
Products and vendors Mallory has correlated with this vulnerability. Open in Mallory to drill down to specific CPE configurations and version ranges.
Vendor-confirmed product mapping. Mallory continuously reconciles this list against your asset inventory.
4 sources tracked across advisories and community write-ups. News coverage will land here when it surfaces.
No news coverage yet. Advisories and community discussion only.
Query your assets running an affected version, and investigate the blast radius.
Every observed campaign linking this CVE to a named adversary.
Malware families riding this exploit, with evidence and IOCs.
YARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.
Cross-references every affected SKU, including bundled OEM variants.
Community discussion across Reddit, Mastodon, and other social sources.